Tor Therapeutics INC
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersMeadowbrook, PA
SAM.gov UEIKUNKSBD59AU9
TOR Therapeutics is developing a fixed dose combination of two mTORC1 inhibitors to treat neurodegenerative diseases, with a lead focus on Alzheimer's Disease to maintain cognitive function and targeting other disorders driven by mTORC1 hyperactivation. The company was founded in 2015 by physicians Jeffrey Melin and Nancy Young.
Summarized from the company’s own website
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Tor Therapeutics INC | Meadowbrook | PA | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.